These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 9514829
1. nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease. Thorns V, Hansen L, Masliah E. Exp Neurol; 1998 Mar; 150(1):14-20. PubMed ID: 9514829 [Abstract] [Full Text] [Related]
2. nNOS expression in reactive astrocytes correlates with increased cell death related DNA damage in the hippocampus and entorhinal cortex in Alzheimer's disease. Simic G, Lucassen PJ, Krsnik Z, Kruslin B, Kostovic I, Winblad B, Bogdanovi. Exp Neurol; 2000 Sep; 165(1):12-26. PubMed ID: 10964481 [Abstract] [Full Text] [Related]
7. Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease. Takeda T, Uchihara T, Arai N, Mizutani T, Iwata M. Acta Neuropathol; 2009 Jan; 117(1):35-44. PubMed ID: 19002475 [Abstract] [Full Text] [Related]
8. Stereologic analysis of hippocampal Alzheimer's disease pathology in the oldest-old: evidence for sparing of the entorhinal cortex and CA1 field. von Gunten A, Kövari E, Rivara CB, Bouras C, Hof PR, Giannakopoulos P. Exp Neurol; 2005 May; 193(1):198-206. PubMed ID: 15817278 [Abstract] [Full Text] [Related]
9. No association between the neuronal nitric oxide synthase gene polymorphism and Alzheimer Disease. Liou YJ, Hong CJ, Liu HC, Liu CY, Liu TY, Chen IC, Tsai SJ. Am J Med Genet; 2002 Aug 08; 114(6):687-8. PubMed ID: 12210288 [Abstract] [Full Text] [Related]
10. Amyloid-beta (25-35) increases activity of neuronal NO-synthase in rat brain. Stepanichev MY, Onufriev MV, Yakovlev AA, Khrenov AI, Peregud DI, Vorontsova ON, Lazareva NA, Gulyaeva NV. Neurochem Int; 2008 May 08; 52(6):1114-24. PubMed ID: 18207612 [Abstract] [Full Text] [Related]
12. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex. van de Nes JA, Nafe R, Schlote W. Brain Res; 2008 Jun 05; 1213():152-65. PubMed ID: 18455153 [Abstract] [Full Text] [Related]
14. Neuronal nitric oxide synthase (nNOS) mRNA expression and NADPH-diaphorase staining in the frontal cortex, visual cortex and hippocampus of control and Alzheimer's disease brains. Norris PJ, Faull RL, Emson PC. Brain Res Mol Brain Res; 1996 Sep 05; 41(1-2):36-49. PubMed ID: 8883932 [Abstract] [Full Text] [Related]
15. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models. Ferrer I, Barrachina M, Puig B, Martínez de Lagrán M, Martí E, Avila J, Dierssen M. Neurobiol Dis; 2005 Nov 05; 20(2):392-400. PubMed ID: 16242644 [Abstract] [Full Text] [Related]
17. Distribution of NADPH-diaphorase and expression of nNOS, N-methyl-D-aspartate receptor (NMDAR1) and non-NMDA glutamate receptor (GlutR2) genes in the neurons of the hippocampus after domoic acid-induced lesions in adult rats. Ananth C, Dheen ST, Gopalakrishnakone P, Kaur C. Hippocampus; 2003 Nov 05; 13(2):260-72. PubMed ID: 12699333 [Abstract] [Full Text] [Related]
19. Significant negative correlations between capillary expressed eNOS and Alzheimer lesion burden. Jeynes B, Provias J. Neurosci Lett; 2009 Oct 09; 463(3):244-8. PubMed ID: 19660523 [Abstract] [Full Text] [Related]
20. Calcium-binding protein secretagogin-expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease. Attems J, Preusser M, Grosinger-Quass M, Wagner L, Lintner F, Jellinger K. Neuropathol Appl Neurobiol; 2008 Feb 09; 34(1):23-32. PubMed ID: 17961140 [Abstract] [Full Text] [Related] Page: [Next] [New Search]